Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Tetraoxane Antimalarials and Their Reaction with Fe(II)

Identifieur interne : 001C16 ( Main/Exploration ); précédent : 001C15; suivant : 001C17

Tetraoxane Antimalarials and Their Reaction with Fe(II)

Auteurs : Igor Opsenica [Monténégro] ; Nataša Terzi [Monténégro] ; Dejan Opsenica [Monténégro] ; Goran Angelovski [Monténégro, Allemagne] ; Manfred Lehnig [Monténégro] ; Peter Eilbracht [Monténégro] ; Bernard Tinant [Monténégro] ; Zorica Jurani [Monténégro] ; Kirsten S. Smith [Monténégro] ; Young S. Yang [Monténégro] ; Damaris S. Diaz [Monténégro] ; Philip L. Smith [Monténégro] ; Wilbur K. Milhous [Monténégro] ; Dejan Dokovi [Monténégro] ; Bogdan A. Šolaja [Monténégro]

Source :

RBID : ISTEX:23A92E883487F0DB36DA1E09575F925E53726FEC

Abstract

Mixed tetraoxanes 5a and 13 synthesized from cholic acid and 4-oxocyclohexanecarboxylic acid were as active as artemisinin against chloroquine-susceptible, chloroquine-resistant, and multidrug-resistant Plasmodium falciparum strains (IC50, IC90). Most active 13 is metabolically stable in in vitro metabolism studies. In vivo studies on tetraoxanes with a C(4‘ ‘) methyl group afforded compound 15, which cured 4/5 mice at 600 and 200 mg·kg-1·day-1, and 2/5 mice at 50 mg·kg-1·day-1, showing no toxic effects. Tetraoxane 19 was an extremely active antiproliferative with LC50 of 17 nM and maximum tolerated dose of 400 mg/kg. In Fe(II)-induced scission of tetraoxane antimalarials only RO• radicals were detected by EPR experiments. This finding and the indication of Fe(IV)O species led us to propose that RO• radicals are probably capable of inducing the parasite's death. Our results suggest that C radicals are possibly not the only lethal species derived from peroxide prodrug antimalarials, as currently believed.

Url:
DOI: 10.1021/jm050966r


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Tetraoxane Antimalarials and Their Reaction with Fe(II)</title>
<author>
<name sortKey="Opsenica, Igor" sort="Opsenica, Igor" uniqKey="Opsenica I" first="Igor" last="Opsenica">Igor Opsenica</name>
</author>
<author>
<name sortKey="Terzi, Natasa" sort="Terzi, Natasa" uniqKey="Terzi N" first="Nataša" last="Terzi">Nataša Terzi</name>
</author>
<author>
<name sortKey="Opsenica, Dejan" sort="Opsenica, Dejan" uniqKey="Opsenica D" first="Dejan" last="Opsenica">Dejan Opsenica</name>
</author>
<author>
<name sortKey="Angelovski, Goran" sort="Angelovski, Goran" uniqKey="Angelovski G" first="Goran" last="Angelovski">Goran Angelovski</name>
</author>
<author>
<name sortKey="Lehnig, Manfred" sort="Lehnig, Manfred" uniqKey="Lehnig M" first="Manfred" last="Lehnig">Manfred Lehnig</name>
</author>
<author>
<name sortKey="Eilbracht, Peter" sort="Eilbracht, Peter" uniqKey="Eilbracht P" first="Peter" last="Eilbracht">Peter Eilbracht</name>
</author>
<author>
<name sortKey="Tinant, Bernard" sort="Tinant, Bernard" uniqKey="Tinant B" first="Bernard" last="Tinant">Bernard Tinant</name>
</author>
<author>
<name sortKey="Jurani, Zorica" sort="Jurani, Zorica" uniqKey="Jurani Z" first="Zorica" last="Jurani">Zorica Jurani</name>
</author>
<author>
<name sortKey="Smith, Kirsten S" sort="Smith, Kirsten S" uniqKey="Smith K" first="Kirsten S." last="Smith">Kirsten S. Smith</name>
</author>
<author>
<name sortKey="Yang, Young S" sort="Yang, Young S" uniqKey="Yang Y" first="Young S." last="Yang">Young S. Yang</name>
</author>
<author>
<name sortKey="Diaz, Damaris S" sort="Diaz, Damaris S" uniqKey="Diaz D" first="Damaris S." last="Diaz">Damaris S. Diaz</name>
</author>
<author>
<name sortKey="Smith, Philip L" sort="Smith, Philip L" uniqKey="Smith P" first="Philip L." last="Smith">Philip L. Smith</name>
</author>
<author>
<name sortKey="Milhous, Wilbur K" sort="Milhous, Wilbur K" uniqKey="Milhous W" first="Wilbur K." last="Milhous">Wilbur K. Milhous</name>
</author>
<author>
<name sortKey="Dokovi, Dejan" sort="Dokovi, Dejan" uniqKey="Dokovi D" first="Dejan" last="Dokovi">Dejan Dokovi</name>
</author>
<author>
<name sortKey="Solaja, Bogdan A" sort="Solaja, Bogdan A" uniqKey="Solaja B" first="Bogdan A." last="Šolaja">Bogdan A. Šolaja</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:23A92E883487F0DB36DA1E09575F925E53726FEC</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1021/jm050966r</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-VC209HG1-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001260</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001260</idno>
<idno type="wicri:Area/Istex/Curation">001260</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A84</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A84</idno>
<idno type="wicri:doubleKey">0022-2623:2006:Opsenica I:tetraoxane:antimalarials:and</idno>
<idno type="wicri:Area/Main/Merge">001C28</idno>
<idno type="wicri:Area/Main/Curation">001C16</idno>
<idno type="wicri:Area/Main/Exploration">001C16</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Tetraoxane Antimalarials and Their Reaction with Fe(II)</title>
<author>
<name sortKey="Opsenica, Igor" sort="Opsenica, Igor" uniqKey="Opsenica I" first="Igor" last="Opsenica">Igor Opsenica</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Terzi, Natasa" sort="Terzi, Natasa" uniqKey="Terzi N" first="Nataša" last="Terzi">Nataša Terzi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Opsenica, Dejan" sort="Opsenica, Dejan" uniqKey="Opsenica D" first="Dejan" last="Opsenica">Dejan Opsenica</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Angelovski, Goran" sort="Angelovski, Goran" uniqKey="Angelovski G" first="Goran" last="Angelovski">Goran Angelovski</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea> Current address:  Max-Planck Institute for Biological Cybernetics,Tübingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lehnig, Manfred" sort="Lehnig, Manfred" uniqKey="Lehnig M" first="Manfred" last="Lehnig">Manfred Lehnig</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Eilbracht, Peter" sort="Eilbracht, Peter" uniqKey="Eilbracht P" first="Peter" last="Eilbracht">Peter Eilbracht</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Tinant, Bernard" sort="Tinant, Bernard" uniqKey="Tinant B" first="Bernard" last="Tinant">Bernard Tinant</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Jurani, Zorica" sort="Jurani, Zorica" uniqKey="Jurani Z" first="Zorica" last="Jurani">Zorica Jurani</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Smith, Kirsten S" sort="Smith, Kirsten S" uniqKey="Smith K" first="Kirsten S." last="Smith">Kirsten S. Smith</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Yang, Young S" sort="Yang, Young S" uniqKey="Yang Y" first="Young S." last="Yang">Young S. Yang</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Diaz, Damaris S" sort="Diaz, Damaris S" uniqKey="Diaz D" first="Damaris S." last="Diaz">Damaris S. Diaz</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Smith, Philip L" sort="Smith, Philip L" uniqKey="Smith P" first="Philip L." last="Smith">Philip L. Smith</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Milhous, Wilbur K" sort="Milhous, Wilbur K" uniqKey="Milhous W" first="Wilbur K." last="Milhous">Wilbur K. Milhous</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Dokovi, Dejan" sort="Dokovi, Dejan" uniqKey="Dokovi D" first="Dejan" last="Dokovi">Dejan Dokovi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Solaja, Bogdan A" sort="Solaja, Bogdan A" uniqKey="Solaja B" first="Bogdan A." last="Šolaja">Bogdan A. Šolaja</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Monténégro</country>
<wicri:regionArea>Institute of Chemistry, Technology and Metallurgy, Belgrade, Serbia and Montenegro, Fachbereich Chemie, Organische Chemie I, UniversitätDortmund, D-44221 Dortmund, Germany, Laboratoire de Chimie Physique et de Cristallographie, Université Catholique de Louvain,Louvain-la-Neuve, Belgium, National Cancer Research Institute, Belgrade, Serbia and Montenegro, Division of Experimental Therapeutics,Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, and Faculty of Chemistry, University of Belgrade, Belgrade</wicri:regionArea>
<wicri:noRegion>Belgrade</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Medicinal Chemistry</title>
<title level="j" type="abbrev">J. Med. Chem.</title>
<idno type="ISSN">0022-2623</idno>
<idno type="eISSN">1520-4804</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published" when="2006-06-08">2006</date>
<date when="2006-06-29">2006</date>
<biblScope unit="vol">49</biblScope>
<biblScope unit="issue">13</biblScope>
<biblScope unit="page" from="3790">3790</biblScope>
<biblScope unit="page" to="3799">3799</biblScope>
</imprint>
<idno type="ISSN">0022-2623</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-2623</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Mixed tetraoxanes 5a and 13 synthesized from cholic acid and 4-oxocyclohexanecarboxylic acid were as active as artemisinin against chloroquine-susceptible, chloroquine-resistant, and multidrug-resistant Plasmodium falciparum strains (IC50, IC90). Most active 13 is metabolically stable in in vitro metabolism studies. In vivo studies on tetraoxanes with a C(4‘ ‘) methyl group afforded compound 15, which cured 4/5 mice at 600 and 200 mg·kg-1·day-1, and 2/5 mice at 50 mg·kg-1·day-1, showing no toxic effects. Tetraoxane 19 was an extremely active antiproliferative with LC50 of 17 nM and maximum tolerated dose of 400 mg/kg. In Fe(II)-induced scission of tetraoxane antimalarials only RO• radicals were detected by EPR experiments. This finding and the indication of Fe(IV)O species led us to propose that RO• radicals are probably capable of inducing the parasite's death. Our results suggest that C radicals are possibly not the only lethal species derived from peroxide prodrug antimalarials, as currently believed.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Monténégro</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Tübingen</li>
</region>
<settlement>
<li>Tübingen</li>
</settlement>
</list>
<tree>
<country name="Monténégro">
<noRegion>
<name sortKey="Opsenica, Igor" sort="Opsenica, Igor" uniqKey="Opsenica I" first="Igor" last="Opsenica">Igor Opsenica</name>
</noRegion>
<name sortKey="Angelovski, Goran" sort="Angelovski, Goran" uniqKey="Angelovski G" first="Goran" last="Angelovski">Goran Angelovski</name>
<name sortKey="Diaz, Damaris S" sort="Diaz, Damaris S" uniqKey="Diaz D" first="Damaris S." last="Diaz">Damaris S. Diaz</name>
<name sortKey="Dokovi, Dejan" sort="Dokovi, Dejan" uniqKey="Dokovi D" first="Dejan" last="Dokovi">Dejan Dokovi</name>
<name sortKey="Eilbracht, Peter" sort="Eilbracht, Peter" uniqKey="Eilbracht P" first="Peter" last="Eilbracht">Peter Eilbracht</name>
<name sortKey="Jurani, Zorica" sort="Jurani, Zorica" uniqKey="Jurani Z" first="Zorica" last="Jurani">Zorica Jurani</name>
<name sortKey="Lehnig, Manfred" sort="Lehnig, Manfred" uniqKey="Lehnig M" first="Manfred" last="Lehnig">Manfred Lehnig</name>
<name sortKey="Milhous, Wilbur K" sort="Milhous, Wilbur K" uniqKey="Milhous W" first="Wilbur K." last="Milhous">Wilbur K. Milhous</name>
<name sortKey="Opsenica, Dejan" sort="Opsenica, Dejan" uniqKey="Opsenica D" first="Dejan" last="Opsenica">Dejan Opsenica</name>
<name sortKey="Smith, Kirsten S" sort="Smith, Kirsten S" uniqKey="Smith K" first="Kirsten S." last="Smith">Kirsten S. Smith</name>
<name sortKey="Smith, Philip L" sort="Smith, Philip L" uniqKey="Smith P" first="Philip L." last="Smith">Philip L. Smith</name>
<name sortKey="Solaja, Bogdan A" sort="Solaja, Bogdan A" uniqKey="Solaja B" first="Bogdan A." last="Šolaja">Bogdan A. Šolaja</name>
<name sortKey="Terzi, Natasa" sort="Terzi, Natasa" uniqKey="Terzi N" first="Nataša" last="Terzi">Nataša Terzi</name>
<name sortKey="Tinant, Bernard" sort="Tinant, Bernard" uniqKey="Tinant B" first="Bernard" last="Tinant">Bernard Tinant</name>
<name sortKey="Yang, Young S" sort="Yang, Young S" uniqKey="Yang Y" first="Young S." last="Yang">Young S. Yang</name>
</country>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Angelovski, Goran" sort="Angelovski, Goran" uniqKey="Angelovski G" first="Goran" last="Angelovski">Goran Angelovski</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C16 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:23A92E883487F0DB36DA1E09575F925E53726FEC
   |texte=   Tetraoxane Antimalarials and Their Reaction with Fe(II)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021